News

More docs need to use available Rx-monitoring programs to help curb opioid abuse

Publish date: October 1, 2014

 

AT A PEW CHARITABLE TRUSTS–HOSTED PANEL

References

gtwachtman@frontlinemedcom.com

Pages

Recommended Reading

DEA moves hydrocodone combination products to schedule II
MDedge Rheumatology
Quality of life gains achieved with comprehensive disease control in RA
MDedge Rheumatology
Emotional exposure therapy studied for fibromyalgia
MDedge Rheumatology
DEA expands drug take-back program to hospitals, clinics
MDedge Rheumatology
Psoriatic arthritis patients often changed or stopped treatment
MDedge Rheumatology
FDA approves drug for opioid-induced constipation in chronic noncancer pain population
MDedge Rheumatology
Stepwise approach improves diagnostic accuracy in polymyalgia rheumatica
MDedge Rheumatology
Hydrocodone rescheduling takes effect Oct. 6
MDedge Rheumatology
Risk factors outweigh benefits of opioids for chronic noncancer pain
MDedge Rheumatology
Acupuncture failed to reduce chronic knee pain
MDedge Rheumatology